The US launched the world's most expensive drug, which cost $ 850,000

According to a reporter in New York, Luxturna - a drug that cure congenital retinal degeneration can lead to complete blindness, will be sold for $ 850,000 in the US , becoming one of the most expensive treatment drugs gender.

According to the manufacturer of this drug, Philadelphia-based Spark Therapeutics, with Luxturna, the patient only needs a single dose.

Luxturna became one of the most expensive drugs in the world.(Illustration).

The price is still lower than the initial $ 1 million level before the company received approval from the Drug Administration (FDA) in mid-December.

The announcement comes amid US public debate over the high cost of medicines, especially for treatments that are thought to be innovative.

Prior to criticism, Spark promised to return money to patients if the treatment did not work, and said they hoped the US health authorities would allow payment of drugs in installments.

There are about 1000 patients suffering from congenital retinal degenerative disease, and an estimated 10-20 new cases each year.

In addition to Luxturna, there are a number of other drugs that cost nearly $ 1 million, but these drugs are usually prescribed several doses.

For example, Spinraza drug (called Nusinersen in Europe) is produced by Biogen and Ionis to treat muscular dystrophy, and Alexion's Soliris drug to treat a rare form of kidney disease. Both drugs cost about $ 750,000.

Currently the most expensive drug in the world belongs to Glybera , produced by the Dutch company UniQure and sold for $ 1 million to treat some genetic diseases.